HIGHLIGHTS
- who: F. Selle et al. from the Alliance for Cancer Research (APREC), Paris, France and Curie University (UPMC Paris VI), Paris, France have published the research: Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer, in the Journal: (JOURNAL)
- what: Although this study reported a 2-year failure-free survival (FFS) of 44.8% (95% CI: 32.5-56.4) for the standard-dose arm compared to 58.2% (95%CI: 48-71.9) for the high-dose arm, the difference was not statistically significant (P=0.060). In breast cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.